Exact Sciences Corporation (EXAS) is an interesting player in the Healthcare space, with a focus on Medical Laboratories & Research. The stock has been active on the tape, currently trading at $47.57, up from yesterday’s close by 0.08%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Exact Sciences Corporation (EXAS) currently trades with a market capitalization of $5.67 Billion. That value represents a market adjusting for revenues that have been growing by 158.13 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$125.21 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of -$0.24 on a per share basis this quarter. Perhaps, that suggests something about why 3.13% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how EXAS has been acting. Looking at the stock’s movement on the chart, Exact Sciences Corporation recorded a 52-week high of $63.60. It is now trading 16.03% off that level. The stock is trading $51.53 its 50-day moving average by 3.96%. The stock carved out a 52-week low down at $18.50.
In recent action, Exact Sciences Corporation (EXAS) has made a move of -10.16% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 13.62, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 10.42% with $117.25 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of EXAS.